fbpx
close read more
Videos

Partnership Servier/OSE Immunotherapeutics

25/08/2021

Partnership Servier/OSE Immunotherapeutics

Servier favors open collaboration to accelerate the development of therapeutic solutions for the benefit of patients. Here is a video example of our partnership with the biotech OSE Immunotherapeutics to advance research in immuno-oncology. In 2021, Servier and French biotech OSE Immunotherapeutics have announced enrollment of the first patient in the Phase 2 clinical trial evaluating the efficacy and safety of monoclonal antibody OSE-127/S95011 in Sjögren’s syndrome.

Latest brochures and media

Brochures
25/05/2022
Brochures on the symptoms and treatment of depression
Videos
11/04/2022
Parkinson’s disease: Servier, a committed stakeholder
Videos
31/03/2022
Partnership Servier / Celsius Therapeutics